Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Growing hair follicles have high mitochondrial activity and ROS in specific regions, aiding hair formation.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The study found that mouse sweat glands develop before birth, mature after birth, and have specific keratin patterns.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Nano-sized lipid particles increase dexamethasone's skin penetration and create a reservoir in the skin layers.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.